Neuropathic Pain News and Research

RSS

Neuropathic pain is a type of pain that is caused by damage to the nervous system following an injury or illness and affects approximately 1% of the population.

Mindfulness can help ease neuropathic pain related to breast cancer treatment

A study led by University of Ottawa researchers provides empirical evidence that mindfulness has a significant impact on the brain of women suffering from neuropathic pain related to breast cancer treatment.

6 Jan 2021

Experts highlight latest advancements in neurogenic classification and pain management

There have been significant advances in knowledge regarding the pathology, etiology, assessment, and treatment of several significant neurogenic pain disorders regularly encountered by neurorehabilitation professionals in both inpatient and outpatient care.

18 Nov 2020

Researchers develop a novel way to simplify cellular optogenetic tools

Cellular optogenetics is a technique that allows researchers to use light to precisely control cell signaling and function in space and time enabling the investigation of mechanisms involved in disease processes.

22 Oct 2020

New technique uses light to modify disease signaling

Most diseases are caused by aberrant cell signaling processes and basic research in cell signaling is needed to identify targets for future therapeutic approaches, especially in cases where no cures or effective treatments are currently available.

22 Oct 2020

SARS-CoV-2 spike protein may induce analgesia

A recent study published in the journal Pain in October 2020 adds another piece to the puzzle, showing that the virus is capable of dulling pain pathways. This may contribute to its early and extensive spread.

7 Oct 2020

DFG establishes new research units

The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is setting up six new Research Units and a new Clinical Research Unit. The DFG Joint Committee decided this on the recommendation of the Senate.

7 Oct 2020

NIH awards $1.9 million STTR grant to fast track new class of non-opioid pain relievers

The National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH) has awarded a $1.9 million Fast-Track Small Business Technology Transfer grant to South Rampart Pharma.

25 Sep 2020

Targeting a key gateway can help treat chronic pain, shows study

Something like a quarter of the world's population suffers from chronic pain at some point. As opposed to acute pain – for example, that feeling after hitting your finger with a hammer – chronic pain may not even have a clear cause, and it can linger for years or lifetimes.

27 Aug 2020

New approach to chronic pain treatment could bring relief

Something like a quarter of the world's population suffers from chronic pain at some point in their lives. As opposed to acute pain - for example, the feeling after hitting your finger with a hammer - chronic pain may not even have a clear cause, and it can linger for years or lifetimes.

19 Aug 2020

UB study validates a novel pharmacological target for Alzheimer’s disease

A UB study published in the journal Neurotherapeutics has validated a new pharmacological target for Alzheimer's disease.

24 Jul 2020

Antiepileptic drug use linked to higher risk of death among people with Alzheimer’s disease

The use of antiepileptic drugs is associated with a higher risk of death among persons with Alzheimer’s disease, according to a new study from the University of Eastern Finland.

4 Jun 2020

Legal Cannabis hemp oil helps reduce chronic neuropathic pain in mice

Researchers examine the effectiveness of consuming hemp oil extracted from the whole Cannabis plant using a chronic neuropathic pain animal model.

20 May 2020

UCD researcher awarded €500,000 SFI Future Innovator Prize for innovative imaging solution

Ireland's Minister for Business, Enterprise, and Innovation, Heather Humphreys, TD, has today announced that a special Science Foundation Ireland Future Innovator Prize of €500,000 has been granted to University College Dublin researcher, Professor Dominic Zerulla.

9 May 2020

Scientists delay onset of amyotrophic lateral sclerosis in mice

A team of researchers led by scientists at the University of Toronto has delayed the onset of amyotrophic lateral sclerosis in mice.

20 Apr 2020

Tarantula venom could be used as a potent pain reliever

Pain relief has come a long way, with many medicines developed to ease pain and promote comfort. Previous research has shown that venom can be a potent pain reliever. Snake venom has been widely studied as a potential source of pain relievers, especially for chronic and debilitating pain. Now, a team of scientists has found that spider venom, particularly from Tarantulas, could be used as a potent pain reliever for various conditions.

14 Apr 2020

Recognizing CDKL5 Deficiency Disorder

News-Medical speaks to Dr. Dan Lavery about the LouLou Foundation, a non-profit organization dedicated to CDLK5 Deficiency Disorder.

17 Mar 2020

A highly conserved protein contributes to sensing mechanical pain, study shows

Researchers at McGill University have discovered that a protein found in the membrane of our sensory neurons are involved in our capacity to feel mechanical pain, laying the foundation for the development of powerful new analgesic drugs.

24 Feb 2020

Scientists use toxin from rattlesnake venom for chronic pain

Rattlesnake (Crotalus adamanteus) is the largest venomous snake in North America, reaching 8 feet and weighing up to 10 pounds. In the past, medical experts believe that the toxin in rattlesnake venom, crotoxin, is a promising compound for the treatment of chronic pain.

18 Feb 2020

Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain

Crotoxin, extracted from the venom of the South American rattlesnake Crotalus durissus terrificus, has been studied for almost a century for its analgesic, anti-inflammatory and antitumor activities and as an even more powerful muscle paralyzer than botulinum toxin.

16 Feb 2020